Agilent Technologies Inc.
Agilent Technologies Announces Organizational Restructuring
Summary
Agilent Technologies, Inc. announced a reorganization of its business structure effective November 2024, resulting in the formation of three new segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The changes are reflected in the recast of certain items in the Annual Report on Form 10-K. This Current Report on Form 8-K includes financial statements and exhibits that support the updated segment information.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement